Patents by Inventor Mark Wainwright

Mark Wainwright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOLUIDINE BLUE DERIVATIVES AS PHOTOSENSITISING COMPOUNDS
    Publication number: 20120328530
    Abstract: A compound of formula (III), or a pharmaceutically acceptable derivative thereof for use in a method of combating and/or detecting a pathogen and/or tumour cells; wherein X is selected from O, S and Se; each of R2, R3 and R4 is independently selected from hydrogen or an optionally substituted alkyl, alkenyl, alkynyl or aryl group; and R1 is selected from halogen, sulfo, acyl, sulfoxy, mercapto, nitro, amino, hydroxy or an optionally substituted alkyl, alkenyl, alkynyl, aryl, amine or alkoxy group; wherein R1 is not methyl or hydrogen when each of R3 and R4 is methyl or hydrogen.
    Type: Application
    Filed: March 11, 2011
    Publication date: December 27, 2012
    Applicant: PHARMALUCIA LIMITED
    Inventor: Mark Wainwright
  • COMPOUNDS AND METHODS RELATING THERETO
    Publication number: 20110306576
    Abstract: A compound of formula (II) or a pharmaceutically acceptable derivative thereof for use in a method of combating and/or detecting a pathogen; wherein X is selected from O, S and Se; each of R1, R2, R4, R6, R8, R9, R11, R12, R13 and R14 is independently selected from hydrogen, halogen, sulfo, sulfoxy, mercapto, acyl, nitro, amino or an optionally substituted alkyl, alkenyl, alkynyl, aryl, amine or alkoxy group; provided that at least one of R11, R12, R13 and R14 is an optionally substituted amine group.
    Type: Application
    Filed: February 25, 2010
    Publication date: December 15, 2011
    Applicant: PHARMALUCIA LIMITED
    Inventor: Mark Wainwright